▷ "K-Medical Global Frontier Seminar" held on Friday, June 20 at EXCO, Daegu
▷ A total of 22 companies and institutions, including Daewoo Pharm Co., participate
 
On June 20, the Daegu-Gyeongbuk Free Economic Zone Authority (DGFEZ), led by Commissioner Kim Byeong-sam, held the K-Medical Global Frontier Seminar at EXCO in Daegu. The event brought together stakeholders from bio-healthcare companies, medical device associations, academic institutions, and public research organizations.
The seminar, hosted by DGFEZ and organized by the Daegu-Gyeongbuk Advanced Medical Innovation Foundation, aimed to share global trends and successful overseas expansion cases in the advanced medical device industry—one of DGFEZ’s core strategic sectors. It also focused on equipping domestic companies with effective strategies to navigate international certifications and regulatory challenges.
Key participants included Daewoo Pharm Co., Ltd., KOTRAS Co., Ltd., PIXELO Inc., INTIN Inc., Venture Blick Korea, Holmes AI, and CONNECTIVE.
In the first session, Inseop Yeo, Director at Venture Blick Korea, delivered a presentation on global healthcare trends and market entry strategies. The second session featured Hye-mi Lee, patent attorney at Taebaek IP Law Firm, and Ji-hoon Kim, CEO of INTIN Inc., who provided in-depth insights into securing overseas patents for AI-based medical devices and CE IVDR (In Vitro Diagnostic Medical Device Regulation) certification in Europe.
Through the seminar, participating companies gained valuable perspectives on the future of the bio-healthcare industry and international market dynamics. They also enhanced their understanding of foreign patent and certification systems, laying the groundwork for successful global expansion. The event also fostered collaboration among companies, research institutes, and key stakeholders within and beyond the DGFEZ, contributing to a virtuous cycle of investment attraction, knowledge exchange, and innovation-driven growth.
Commissioner Kim stated,
“This seminar plays a key role in strengthening DGFEZ’s innovation ecosystem. By enhancing the global readiness and business development capabilities of companies in the bio-healthcare and advanced medical device sectors, we aim to support their evolution into globally competitive enterprises—and further establish DGFEZ as a leading hub for international business.”